8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione Linagliptin 668270-12-0 Tradjenta BI-1356 BI 1356 Trazenta Trajenta BI-1356-BS linagliptine Linagliptina BS 1356 BS BI1356 3X29ZEJ4R2 (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione BI-1356BS BI 1356 BS BS-1356-BS CHEBI:68610 DTXSID201021653 GLYXAMBI COMPONENT LINAGLIPTIN (R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione 1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- TRIJARDY XR COMPONENT LINAGLIPTIN 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione linagliptinum 8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE RefChem:5948 1356, BI A10BH05 DTXCID801506661 Ondero Linagliptin (BI-1356) MFCD14635356 ione CHEMBL237500 C25H28N8O2 (R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (R)-8-[3-Aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine 1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione 8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione UNII-3X29ZEJ4R2 Linaglitpin Linagliptin [USAN:INN:JAN] HSDB 8204 Tradjenta (TN) 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione Linagliptin (Standard) LINAGLIPTIN [MI] LINAGLIPTIN [INN] LINAGLIPTIN [JAN] LINAGLIPTIN [USAN] LINAGLIPTIN [VANDF] LINAGLIPTIN [MART.] LINAGLIPTIN [WHO-DD] Linagliptin (BI-1356)? MLS006010217 SCHEMBL160188 Linagliptin (JAN/USAN/INN) GTPL6318 orb1310851 orb3141336 Linagliptin - Bio-X trade mark SCHEMBL29359185 EX-A076 LINAGLIPTIN [ORANGE BOOK] LTXREWYXXSTFRX-QGZVFWFLSA-N GLXC-10521 MSK15589 BDBM50228403 EBC-13284 HY-10284R s3031 AKOS015951179 AKOS015995251 AC-8761 CCG-269463 CS-0637 DB08882 FL24893 NCGC00346655-01 NCGC00346655-02 NCGC00346655-08 1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- 8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione AS-35080 BL164627 DA-54932 HY-10284 SMR004701306 NS00098773 SW219813-1 D09566 AB01563307_01 AB01563307_03 EN300-6481354 Q909745 BRD-K96550715-001-02-6 BRD-K96550715-001-03-4 BRD-K96550715-001-04-2 BRD-K96550715-003-01-4 Z2235801970 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine 1-[(4-methyl-quinazolin-2yl) methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R) amino-piperidin-1-yl]-xanthine 1-[(4-Methylquinazolin-2-yl)-methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine 1233245-11-8 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d
Mostrar todos os 113 sinônimos